Probiotics Effect in Reducing Behavioral Symptoms and Severity of Autism

Phase 2

Recruiting

• Conditions: Childhood autism; Autism Spectrum Disorder.

• Registration Number: IRCT20130504013215N2
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 June 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

All patients with autism between 3 and 18 years of age

Exclusion Criteria

Suffering from chronic infectious diseases
Congenital metabolic disorders
HIV and Congenital Immunodeficiency Disorder
Under treatment with anti-fungal drugs, antibiotics, anti-inflammatory drugs, corticosteroids, anti-diarrheal compounds, chemotherapy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in symptoms of autism disorder in the CARS questionnaire. Timepoint: When entering the study and 8 weeks after starting treatment. Method of measurement: CARS questionnaire at the beginning and the end of the study.;Change in severity of autism disorder in the ATEC questionnaire. Timepoint: When entering the study and 8 weeks after starting treatment. Method of measurement: ATEC questionnaire at the beginning and the end of the study.